Worker, Amanda
Berthert, Pierre
Lawrence, Andrew J.
Kia, Seyed Mostafa
Arango, Celso http://orcid.org/0000-0003-3382-4754
Dinga, Richard http://orcid.org/0000-0003-3040-1297
Galderisi, Silvana
Glenthøj, Birte http://orcid.org/0000-0003-3056-7262
Kahn, René S. http://orcid.org/0000-0001-5909-8004
Leslie, Anoushka
Murray, Robin M. http://orcid.org/0000-0003-0829-0519
Pariante, Carmine M. http://orcid.org/0000-0002-9132-5091
Pantelis, Christos http://orcid.org/0000-0002-9565-0238
Weiser, Mark http://orcid.org/0000-0003-3638-0271
Winter-van Rossum, Inge
McGuire, Philip
Dazzan, Paola http://orcid.org/0000-0002-8427-3617
Marquand, Andre F. http://orcid.org/0000-0001-5903-203X
Article History
Received: 20 September 2022
Revised: 3 November 2023
Accepted: 9 November 2023
First Online: 2 December 2023
Competing interests
: Dr. Glenthøj has been the leader of a Lundbeck Foundation Centre of Excellence for Clinical Intervention and Neuropsychiatric Schizophrenia Research (CINS) (January 2009 – December 2021), which was partially financed by an independent grant from the Lundbeck Foundation based on international review and partially financed by the Mental Health Services in the Capital Region of Denmark, the University of Copenhagen, and other foundations. All grants are the property of the Mental Health Services in the Capital Region of Denmark and administrated by them. She has no other conflicts to disclose. Dr. Arango has been a consultant to or has received honoraria or grants from Acadia, Angelini, Biogen, Boehringer, Gedeon Richter, Janssen Cilag, Lundbeck, Medscape, Menarini, Minerva, Otsuka, Pfizer, Roche, Sage, Servier, Shire, Schering Plough, Sumitomo Dainippon Pharma, Sunovion and Takeda.